THY1 and hepatocellular carcinoma: In our previous study, using the surface marker CD90 (Thy-1, expressed by hepatic stem/progenitor cells), liver CSCs were identified in HCC cell lines, tumor specimens and peripheral blood samples of HCC patients and these CD90+CSCs displayed tumorigenic capacity [9].